Verastem Inc. Stock
Verastem Inc. Stock
Verastem Inc. took a tumble today and lost -€7.520 (-66.550%).
Verastem Inc. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
With a target price of 24 € there is potential for a 538.3% increase which would mean more than doubling the current price of 3.76 € for Verastem Inc..
Our community identified positive and negative aspects for Verastem Inc. stock for the coming years. 6 users see the criterium "Worthwhile Investment for the next years" as a plus for the Verastem Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Verastem Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Verastem Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Verastem Inc. | -66.550% | -64.528% | -56.782% | -23.726% | -50.199% | -90.539% | - |
Ardelyx Inc. | -10.570% | -13.495% | 3.392% | 89.573% | 7.578% | 9.088% | - |
Evolus Inc | -5.830% | -8.130% | 6.604% | 32.164% | 24.862% | 51.678% | - |
Salarius Pharmaceuticals Inc. | 5.580% | 0.971% | -2.804% | -69.412% | -25.045% | -98.384% | -99.993% |
Comments
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat